chr4-54285873-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_006206.6(PDGFRA):​c.2472C>T​(p.Val824Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.16 in 1,613,562 control chromosomes in the GnomAD database, including 23,115 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3681 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19434 hom. )

Consequence

PDGFRA
NM_006206.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.640
Variant links:
Genes affected
PDGFRA (HGNC:8803): (platelet derived growth factor receptor alpha) This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.21).
BP6
Variant 4-54285873-C-T is Benign according to our data. Variant chr4-54285873-C-T is described in ClinVar as [Benign]. Clinvar id is 259951.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.64 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDGFRANM_006206.6 linkc.2472C>T p.Val824Val synonymous_variant Exon 18 of 23 ENST00000257290.10 NP_006197.1 P16234-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDGFRAENST00000257290.10 linkc.2472C>T p.Val824Val synonymous_variant Exon 18 of 23 1 NM_006206.6 ENSP00000257290.5 P16234-1
ENSG00000282278ENST00000507166.5 linkc.1752C>T p.Val584Val synonymous_variant Exon 19 of 24 2 ENSP00000423325.1 A0A0B4J203

Frequencies

GnomAD3 genomes
AF:
0.202
AC:
30628
AN:
151998
Hom.:
3682
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.323
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.235
Gnomad ASJ
AF:
0.0683
Gnomad EAS
AF:
0.143
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.143
Gnomad OTH
AF:
0.168
GnomAD3 exomes
AF:
0.183
AC:
46035
AN:
251358
Hom.:
5051
AF XY:
0.177
AC XY:
24023
AN XY:
135846
show subpopulations
Gnomad AFR exome
AF:
0.329
Gnomad AMR exome
AF:
0.314
Gnomad ASJ exome
AF:
0.0740
Gnomad EAS exome
AF:
0.141
Gnomad SAS exome
AF:
0.217
Gnomad FIN exome
AF:
0.127
Gnomad NFE exome
AF:
0.142
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.156
AC:
227945
AN:
1461444
Hom.:
19434
Cov.:
34
AF XY:
0.155
AC XY:
112889
AN XY:
727076
show subpopulations
Gnomad4 AFR exome
AF:
0.327
Gnomad4 AMR exome
AF:
0.304
Gnomad4 ASJ exome
AF:
0.0783
Gnomad4 EAS exome
AF:
0.141
Gnomad4 SAS exome
AF:
0.214
Gnomad4 FIN exome
AF:
0.126
Gnomad4 NFE exome
AF:
0.145
Gnomad4 OTH exome
AF:
0.152
GnomAD4 genome
AF:
0.201
AC:
30643
AN:
152118
Hom.:
3681
Cov.:
32
AF XY:
0.201
AC XY:
14956
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.323
Gnomad4 AMR
AF:
0.235
Gnomad4 ASJ
AF:
0.0683
Gnomad4 EAS
AF:
0.143
Gnomad4 SAS
AF:
0.236
Gnomad4 FIN
AF:
0.130
Gnomad4 NFE
AF:
0.143
Gnomad4 OTH
AF:
0.166
Alfa
AF:
0.154
Hom.:
4733
Bravo
AF:
0.215
Asia WGS
AF:
0.211
AC:
732
AN:
3478
EpiCase
AF:
0.135
EpiControl
AF:
0.135

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Jun 22, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Gastrointestinal stromal tumor Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Idiopathic hypereosinophilic syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Hereditary cancer-predisposing syndrome Benign:1
May 08, 2019
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.21
CADD
Benign
8.1
DANN
Benign
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2228230; hg19: chr4-55152040; COSMIC: COSV57264143; COSMIC: COSV57264143; API